Dr. Jeffrey Y. Lin, MD

Dr. Lin practices at Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System.

Dr. Lin's NPI, 1770556797, was assigned on February 9, 2006. Dr. Lin graduated from Albany Medical College of Union University in 1984. Dr. Lin holds District of Columbia license MD19002.

Dr. Lin's primary practice is Sibley Memorial Hospital, at 5255 Loughboro Rd NW, Washington, DC 20016 in The District County. The practice phone is (202) 537-4680.

Dr. Lin's primary practice is Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System. Dr. Lin is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Lin to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Lin's licenses on file in 2 states: District of Columbia and Maryland.

CMS data shows 724 Medicare services from Dr. Lin across 11 procedure codes in 2024, for 343 Medicare patients. Medicare paid $93,744 for them.

CMS counts 343 Medicare patients who saw Dr. Lin in 2024. The largest group is 75 to 84, with 149 patients. 74% of them have high cholesterol, and 63% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 62, with 98% women.

In 2024, Dr. Lin wrote 210 Medicare Part D claims for 86 patients. 76% of them were for generic drugs. CMS names the drug for 99 of them, across 5 drugs with 11 or more claims each, at $14,868 in total drug cost. In 2023, CMS named 88 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Lin for performance year 2024, reported as part of a group. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Lin, published from 2017 to 2025. The most frequent topics are DNA Mutational Analysis, Endometrial Neoplasms and Ovarian Neoplasms. Dr. Lin has published most often in Am J Surg Pathol. Dr. Lin's most frequent co-authors are Alexander Baras, MD, PhD, Jaden Rachel Schupp Kohn, MD, MPH and Kimberly Lynn Levinson, MD, MPH.

CMS Open Payments shows 20 general payments to Dr. Lin from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Silk Road Medical, Inc. paid the most, $156.

Dr. Lin graduated from Albany Medical College of Union University in 1984.